Search

Your search keyword '"Pharmacy -- Economic aspects"' showing total 505 results
Start Over Descriptor "Pharmacy -- Economic aspects"
505 results on '"Pharmacy -- Economic aspects"'

1. Pharmacy career immune to recession, economic downturns; offers diverse job avenues

Subjects
Health care industry -- Economic aspects, Pharmacy -- Economic aspects, Recessions -- Economic aspects, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

Byline: Nandita Vijayasimha Pharmacy career is viewed as recession-resistant due to several key factors that contribute to its resilience during economic downturns. The ongoing advancement in pharmaceutical sciences and the [...]

Published
2024

2. Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease

Author

McClure, Graham R., Mclntyre, William F., Belesiotis, Peter, Kaplovitch, Eric, Chan, Noel, Bhagirath, Vinai, Chahill, Gurneet, Hayes, Abigail, Sohi, Gursharan, Bordman, Wendy, Whitlock, Richard P., Anand, Sonia S., and Belley-Cote, Emilie P.

Subjects
Bayer AG, Rivaroxaban -- Economic aspects, Peripheral vascular diseases -- Economic aspects, Cardiology -- Economic aspects, Generic drugs -- Economic aspects, Patient compliance -- Economic aspects, Drugs -- Prescribing, Prescription writing -- Economic aspects, Drugstores -- Economic aspects, Clopidogrel -- Economic aspects, Pharmacy -- Economic aspects, Health, Health care industry
Abstract

Background: Given that peripheral arterial disease (PAD) disproportionately affects people of lower socioeconomic status, out-of-pocket expenses for preventive medications are a major barrier to their use. We carried out a cost comparison of drug therapies for PAD to identify prescribing strategies that minimize out-of-pocket expenses for these medications. Methods: Between March and June 2019, we contacted outpatient pharmacies in Hamilton, Ontario, Canada, to assess pricing of pharmacologic therapies at dosages included in the 2016 American College of Cardiology/American Heart Association guideline for management of lower extremity PAD. We also gathered pricing information for supplementary charges, including delivery, pill splitting and blister packaging. We calculated prescription prices with and without dispensing fees for 30-day brand-name and generic prescriptions, and 90-day generic prescriptions. Results: Twenty-four pharmacies, including hospital-based, independent and chain, were included in our sample. In the most extreme scenario, total 90-day medication costs could differ by up to $1377.26. Costs were affected by choice of agent within a drug class, generic versus brand-name drug, quantity dispensed, dispensing fee and delivery cost, if any. Conclusion: By opting for prescriptions for 90 days or as long as possible, selecting the lowest-cost generic drugs available in each drug class, and identifying dispensing locations with lower fees, prescribers can minimize out-of-pocket patient medication expenses. This may help improve adherence to guideline-recommended therapies for the secondary prevention of vascular events in patients with PAD. Contexte : La maladie artérielle périphérique (MAP) affectant de manière disproportionnée les personnes à faible statut socioéconomique, les dépenses personnelles liées aux médicaments préventifs restreignent fortement leur utilisation. Nous avons comparé les coûts des traitements médicamenteux de la MAP pour cerner des stratégies de prescription qui réduisent au minimum les dépenses personnelles associées. Méthodes : Entre mars et juin 2019, nous avons contacté des pharmacies pour patients externes à Hamilton (Ontario, Canada) afin d'évaluer la tarification de traitements pharmacologiques aux doses incluses dans la ligne directrice de prise en charge de la MAP des membres inférieurs publiée en 2016 par l'American College of Cardiology et l'American Heart Association. Nous avons aussi recueilli des informations sur les frais supplémentaires, dont ceux pour la livraison, la coupe des comprimés et l'emballage. Nous avons calculé le prix d'un approvisionnement de 30 jours de médicaments d'ordonnance génériques et de marque et d'un approvisionnement de 90 jours de médicaments d'ordonnance génériques avec et sans frais d'exécution d'ordonnance. Résultats : Notre échantillon comprenait 24 pharmacies, dont des pharmacies d'hôpital, indépendantes et faisant partie d'une chaîne. La différence la plus élevée pour le prix total d'un approvisionnement de 90 jours de médicaments a atteint 1377,26 $. Les paramètres de variation des coûts comprenaient l'agent choisi dans une classe de médicaments, l'emploi d'un médicament générique ou de marque, la quantité délivrée, les frais d'exécution d'ordonnance et les frais de livraison, le cas échéant. Conclusion : Pour réduire au minimum les dépenses personnelles liées aux médicaments, les médecins prescripteurs peuvent privilégier une ordonnance de 90 jours ou d'une durée aussi longue que possible, choisir les médicaments génériques les moins chers dans chaque classe et repérer les établissements de distribution aux frais inférieurs. Cela peut améliorer l'adhésion aux thérapies recommandées par la ligne directrice pour la prévention secondaire d'accidents vasculaires chez les patients atteints de MAP., An estimated 1.5 million Canadians older than 40 years live with symptomatic peripheral artery disease (PAD), and globally it affects more than 230 million people, a burden that will rise [...]

Published
2024
Full Text
View/download PDF

3. Lord Mawson ask His Majesty's Government what was the cost to the NHS of anti-depressants in each of the past ten years; and how many they prescribed in each of those years

Subjects
Antidepressants -- Economic aspects, Drugs -- Prescribing, Pharmacy -- Economic aspects, Business, international
Abstract

London: UK Parliament has issued the following written answer: Answer Baroness Merron Answered on 23 January 2025 The Prescription Cost Analysis (PCA) provides the total number of prescription items of [...]

Published
2025

4. Functional Medicine Associated with Lower Pharmacy Claim Costs and Offers New Path Forward in Delivery of Patient Care

Subjects
Economic aspects, Health care costs -- Economic aspects, Pharmacy -- Economic aspects, Health insurance -- Economic aspects, Medical schools -- Economic aspects, Medical care, Cost of -- Economic aspects, Medical colleges -- Economic aspects
Abstract

FEDERAL WAY, Wash: The Institute For Functional Medicine has issued the following news release: A groundbreaking study published in October 2024 demonstrates the long-term impact of integrating functional medicine principles [...]

Published
2024

5. PHARMACY STEPS UP TO HANDLE DRUG SHORTAGES, BUT AT WHAT COSTS?

Subjects
Pharmacy -- Economic aspects, Product shortage, News, opinion and commentary
Abstract

BETHESDA, Md. -- The following information was released by the American Society of Health Systems Pharmacists (ASHP): A White House official urged pharmacists to communicate publicly how much drug shortages [...]

Published
2024

6. Pharmacies set to cut their hours or close completely; 'Unlike most businesses pharmacies cannot pass costs onto their patients'

Subjects
Pharmacists -- Economic aspects, Drugstores -- Finance -- Economic aspects, Pharmacy -- Economic aspects, Company financing, General interest, News, opinion and commentary
Abstract

Byline: By, Neil Shaw Pharmacies could be forced to cut their opening hours or close completely if they are not shielded from the tax hikes and increased national living wage [...]

Published
2024

7. COVID-19 Vaccines: A Shot in the Arm for the Economy

Author

Hansen, Niels-Jakob H. and Mano, Rui C.

Subjects
Vaccination -- Economic aspects, Drugstores -- Economic aspects, Unemployment -- Economic aspects, Economic conditions -- Economic aspects, Pharmacy -- Economic aspects, Vaccines -- Economic aspects, Banking, finance and accounting industries, Business, Business, international, International Monetary Fund
Abstract

We quantify the effect of vaccinations on economic activity in the United States using weekly county-level data covering the period end-2020 to mid-2021 .Causal effects are identified through instrumenting vaccination rates with county-level pharmacy density interacted with state-level vaccine allocations, and by including county and state-time fixed effects to control for unobserved factors. We find that vaccinations are a significant and substantial shot in the arm of the economy. Specifically, spending rises by 1.3 percentage points (relative to the average spending during January 2020) in response to a 1% point increase in initiated vaccination rates. Initial unemployment decreases by 0.09 percentage points of the 2019 labor force. Vaccinations also increase workplace mobility. Urban counties and counties with initially worse socioeconomic conditions and lower education levels exhibit larger effects of vaccinations. Keywords COVID-19 * Pandemics * Vaccinations JEL Classifications E52 * E58 * D43 * L11, 1 Introduction Around the world, COVID vaccines are being rolled out. The aim of these vaccination programs is to counter the spread of COVID-19 and put an end to the [...]

Published
2023
Full Text
View/download PDF

8. Hippo Pharmacy Unveils Redesigned Website to Enhance Affordable Access to Prescription Medications

Subjects
Company Web site/Web page, Drugs -- Prescribing -- Economic aspects, Drugstores -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, Web sites -- Economic aspects
Abstract

Hippo Pharmacy has launched a redesigned website to make purchasing prescription medications like Ozempic, Mounjaro, Wegovy, and Rybelsus from Canada more affordable and convenient for U.S. patients. The updated platform [...]

Published
2024

9. Amid Rising Costs, XRP Healthcare Prescription Savings Card Making a Difference at 68,000 Pharmacies Across America: A Game-Changer for Individuals and Organizations Alike

Subjects
Walgreen Co., Walmart Inc., Medical care, Cost of -- Economic aspects, Discount stores -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Hypertension -- Economic aspects, General interest, News, opinion and commentary
Abstract

DUBAI: XRP Healthcare has issued the following news release: Amid rising costs in the U.S., the XRP Healthcare Prescription Savings Card is providing Americans with much-needed relief on medication expenses. [...]

Published
2024

10. Amid Rising Costs, XRP Healthcare Prescription Savings Card Making a Difference at 68,000 Pharmacies Across America: A Game-Changer for Individuals and Organizations Alike

Subjects
Medical care, Cost of -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Hypertension -- Economic aspects
Abstract

DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Amid rising costs in the U.S., the XRP Healthcare Prescription Savings Card is providing Americans with much-needed relief on medication expenses. Accepted at [...]

Published
2024

11. Wolters Kluwer: Two-thirds of Americans say healthcare access and costs will impact their voting decisions

Subjects
Wolters Kluwer N.V., Medical care, Cost of -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Presidents -- Elections, Pharmaceutical policy -- Economic aspects, Business, international
Abstract

Alphen aan den Rijn, Netherlands: Wolters Kluwer has issued the following press release: With the 2024 U.S. election approaching, consumers are facing a healthcare landscape undergoing extreme changes, as pharmacy [...]

Published
2024

12. Wolters Kluwer: Two-thirds of Americans Say Healthcare Access and Costs Will Impact Their Voting Decisions

Subjects
Medical care, Cost of -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Presidents -- Elections, Pharmaceutical policy -- Economic aspects, Business, Business, international
Abstract

Wolters Kluwer Pharmacy Next survey spotlights Americans' 'medicine cabinet issues' and healthcare worries as election nears WALTHAM, Mass. -- With the 2024 U.S. election approaching, consumers are facing a healthcare [...]

Published
2024

14. North Carolina Medicaid recipients can obtain OTC birth control pills at pharmacies at no cost

Subjects
Opill (Contraceptive), Birth control -- Economic aspects, Nonprescription drugs -- Economic aspects, Medicaid -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Oral contraceptives -- Economic aspects
Abstract

CHAPEL HILL, N.C. (AP) — North Carolina Medicaid recipients can begin receiving over-the-counter birth control pills at no cost this week through hundreds of participating pharmacies. The oral conceptive Opill […]

Published
2024

15. Vizient releases its summer pharmacy market outlook projecting drug price inflation at 3.81pc

Subjects
Drugstores -- Economic aspects, Inflation (Finance) -- Economic aspects, Drugs -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, General interest, News, opinion and commentary
Abstract

IRVING: Vizient, Inc. released its summer pharmacy market outlook estimating the 2025 overall drug price inflation rate for pharmaceuticals at 3.81per cent based in part on expanding indications of previously [...]

Published
2024

16. Vizient Projects Drug Price Inflation at 3.81%

Subjects
Drugstores -- Economic aspects, Inflation (Finance) -- Texas, Drugs -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, Business, Business, international
Abstract

'Outlook' urges health systems to prepare for cell and gene therapy expansion IRVING, Texas -- Vizient, Inc. released its summer Pharmacy Market Outlook estimating the 2025 overall drug price inflation [...]

Published
2024

17. FDB Velatm and RxEOB(r) Deliver Transparent Pricing and Pharmacy Options to Consumers to Inform Choice and Savings on Medications

Subjects
First DataBank Inc., Patient compliance -- Economic aspects, Computer services industry -- Economic aspects, Medical informatics -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Computer services industry, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: FDB (First Databank) has issued the following news release: FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, and [...]

Published
2024

19. FDB Vela(TM) and RxEOB Deliver Transparent Pricing and Pharmacy Options to Consumers to Inform Choice and Savings on Medications

Subjects
Patient compliance -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Business, News, opinion and commentary
Abstract

Consumer drug costs -- on-benefit, off-benefit, and discount prices --across pharmacies available on mobile devices saves consumers time and money SOUTH SAN FRANCISCO, Calif, and RICHMOND, Va., June 25, 2024 [...]

Published
2024

20. Faast Pharmacy - Leading the Way in Affordable Prescription Medication Delivery

Subjects
Drugs -- Prescribing -- Economic aspects, Pharmacy -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-June 17, 2024-: Faast Pharmacy - Leading the Way in Affordable Prescription Medication Delivery (C)1994-2024 M2 COMMUNICATIONS RDATE:17062024 Faast Pharmacy, a premier online pharmacy, is revolutionizing the way people [...]

Published
2024

23. RURAL ECONOMIC DEVELOPMENT CENTER IN TONG'AN DISTRICT, XIAMEN CITY invites tenders for Ecological Tea Garden Control Rule Pharmacy Procurement

Subjects
Purchasing -- Economic aspects, Economic development -- China, Pharmacy -- Economic aspects, News, opinion and commentary
Abstract

RURAL ECONOMIC DEVELOPMENT CENTER IN TONG'AN DISTRICT, XIAMEN CITY, China has invited tenders for Ecological Tea Garden Control Rule Pharmacy Procurement. Tender Notice No: 20243019B Deadline: April 25, 2024 Copyright [...]

Published
2024

25. ScriptSave and Rx Outreach use first-of-its-kind tool to reduce medication costs for America's most vulnerable people

Subjects
Patient compliance -- Economic aspects, Drugstores -- Economic aspects, Health care industry -- Economic aspects, Drugs -- Economic aspects, Pharmacy -- Economic aspects, Health care industry, Business, News, opinion and commentary
Abstract

Dedicated wireless device enables clinics to identify the pharmacy with the lowest-cost drug for each patient TUCSON, Ariz. and ST. LOUIS, May 29, 2024 /PRNewswire/ -- ScriptSave, a trusted provider [...]

Published
2024

26. Milliman Medical Index estimates 2024 cost of healthcare for American individual is $7,151; cost for family of four is $32,066

Subjects
Milliman Inc., Medical care, Cost of -- Economic aspects, Drugs -- Prescribing, Pharmacy -- Economic aspects, Health insurance -- Economic aspects, Business, Business, international
Abstract

Healthcare costs for the average person increased 6.7% from 2023 to 2024, with pharmacy costs contributing nearly half of this year's cost increase SEATTLE -- Milliman, Inc., a premier global [...]

Published
2024

27. EU Contract Notice: Asc srl unipersonale Issues contract notice|solicitation for 'Open procedure for the assignment of the ordinary supply of medicines, parapharmaceuticals and other products that can be sold in the municipal pharmacies of Calcinato (BS) through the signing of a framework agreement with two economic operators for a duration of 48 months.'

Subjects
Drugstores -- Contracts, Drugs -- Economic aspects, Pharmacy -- Economic aspects, Amendments (Parliamentary practice) -- Economic aspects, Contract agreement, Business, international
Abstract

Luxembourg: Asc srl unipersonale has issued contract notice/solicitation for 'Open procedure for the assignment of the ordinary supply of medicines, parapharmaceuticals and other products that can be sold in the [...]

Published
2024

28. Florida's Zero Cost Charitable Pharmacy for the Needy by Rombool Charitable Pharmacy

Subjects
Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-April 9, 2024-: Florida's Zero Cost Charitable Pharmacy for the Needy by Rombool Charitable Pharmacy (C)1994-2024 M2 COMMUNICATIONS RDATE:08042024 Brandon, Florida -- Rombool Charitable Pharmacy (RCP) is excited to [...]

Published
2024

29. Blue Shield of California COO Sandra Clarke Joins White House Panel Hosted by President Biden's Team on Pharmacy and Drug Cost Reforms Needed for All Americans

Subjects
Drugs -- Prescribing -- Economic aspects, Chief operating officers -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Business, international
Abstract

Blue Shield of California's COO Sandra Clarke joined a White House panel on pharmacy and drug cost reforms. The company aims to lower drug costs and improve pharmacy care, with [...]

Published
2024

30. ICYMI: NCPA PARTICIPATES IN WHITE HOUSE ROUNDTABLE ON HEALTH CARE COSTS

Subjects
Pharmacists -- Economic aspects, Medical care, Cost of -- Economic aspects, Pharmacy -- Economic aspects, News, opinion and commentary, National Community Pharmacists Association
Abstract

ALEXANDRIA, VA -- The following information was released by the National Community Pharmacists Association (NCPA): On Monday, two NCPA pharmacy owners participated in a special White House roundtable discussion on [...]

Published
2024

31. CMS Releases Part Two Of Guidance For The Inflation Reduction Act's Medicare Prescription Payment Plan

Subjects
United States. Centers for Medicare and Medicaid Services, Health care reform -- Economic aspects, Medicare -- Economic aspects, Medical economics -- Economic aspects, Drugs -- Prescribing, Drugstores -- Economic aspects, Inflation (Finance) -- Economic aspects, Pharmacy -- Economic aspects, Business, international
Abstract

On February 15, 2024, the Centers for Medicare and Medicaid Services (CMS) released the Medicare Prescription Payment Plan Draft Part Two Guidance (Part Two Guidance) as part of the Inflation [...]

Published
2024

32. NCPA PARTICIPATES IN WHITE HOUSE ROUNDTABLE ON HEALTH CARE COSTS

Subjects
Pharmacists -- Economic aspects, Medical care, Cost of -- Economic aspects, Pharmacy -- Economic aspects, News, opinion and commentary, National Community Pharmacists Association
Abstract

ALEXANDRIA, VA -- The following information was released by the National Community Pharmacists Association (NCPA): Yesterday, two NCPA pharmacy owners participated in a special White House roundtable discussion on lowering [...]

Published
2024

33. Waltz Health Unveils New Solution to Lower Specialty Medication Costs

Author

Plescia, Marissa

Subjects
Drugstores -- Economic aspects, Drugs -- Economic aspects, Pharmacy -- Economic aspects, Health insurance -- Economic aspects
Abstract

https://medcitynews.com/2024/08/waltz-health-specialty-drug-costs/ Waltz Health launched Waltz Connect on Monday. The solution supports payers and aims to lower specialty drug costs. The post https://medcitynews.com/2024/08/waltz-health-specialty-drug-costs/ appeared first on https://medcitynews.com Waltz Health, a digital [...]

Published
2024

35. Data from Faculty of Pharmacy Provide New Insights into Sepsis (Cost-effectiveness of De Novo Simvastatin As Adjunctive Therapy In Patients Ill With)

Subjects
Simvastatin -- Economic aspects, Antilipemic agents -- Economic aspects, Infection -- Economic aspects, Pharmacy -- Economic aspects, Physical fitness -- Economic aspects, Health
Abstract

2023 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Blood Diseases and Conditions - Sepsis. According [...]

Published
2023

37. ITV The Martin Lewis Money Show fans can't believe star's 'cheeky' Boots email about Viagra; Martin Lewis shared that he'd received a questionable email from high street pharmacy giants Boots about unbelievable Black Friday sale deals on Viagra

Subjects
Electronic mail systems -- Economic aspects, Impotence -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Anti-impotence agents -- Economic aspects, E-mail, General interest, News, opinion and commentary, Viagra (Medication)
Abstract

Byline: By, Harry Rutter Martin Lewis fans were left gobsmacked after he revealed a 'cheeky' email from brazen Boots about an unbelievable Black Friday sale on Viagra. The cost cutter [...]

Published
2023

39. Study exposes high cost of pharmacies printing medical information leaflets

Subjects
Container industry -- Economic aspects, Medical economics -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Medical advice systems -- Economic aspects, Business, international, European Union. European Commission
Abstract

The Hague: European Carton Makers Association has issued the following news release: MLPS (Medical Leaflet = Patient Safety), a subgroup of the European Carton Manufacturers Association (ECMA), is releasing a [...]

Published
2024

40. Generics Giants; Spotlighting leading generics firms helping to keep drug costs down

Author

Levy, Sandra

Subjects
United States. Food and Drug Administration -- Officials and employees, Dr. Reddy's Laboratories Ltd. -- Officials and employees, Tranexamic acid -- Economic aspects, Aripiprazole -- Economic aspects, Medical care, Cost of -- Economic aspects, Succinylcholine -- Economic aspects, Generic drugs -- Economic aspects, Drugs -- Prescribing, Pharmacy -- Economic aspects, Valsartan -- Economic aspects, Pharmaceutical industry -- Officials and employees, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Generics continue to ensure huge cost savings for the U.S. healthcare system. The latest report from IQVIA and the Association for Accessible Medicines, 'The Case for Competition: 2019 Generic Drug [...]

Published
2020

41. Cost of living help on prescription

Subjects
Cost and standard of living -- Economic aspects, City councils -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Business, international
Abstract

London: Manchester City Council, UK Government has issued the following news release: Manchester's pharmacies are leading the way in putting cost of living support right at the heart of healthcare. [...]

Published
2023

42. Cost of living help on prescription

Subjects
Cost and standard of living -- Economic aspects, City councils -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-December 11, 2023-: Cost of living help on prescription (C)1994-2023 M2 COMMUNICATIONS RDATE:11122023 Manchester's pharmacies are leading the way in putting cost of living support right at the heart [...]

Published
2023

43. FDA approves OTC naloxone, but will cost be a barrier?

Author

Ault, Alicia

Subjects
United States. Food and Drug Administration, Walgreen Co., Nonprescription drugs -- Economic aspects, Drugstores -- Economic aspects, Naloxone -- Economic aspects, Pharmacy -- Economic aspects, Drug approval -- Economic aspects, Health, Narcan (Medication)
Abstract

The US Food and Drug Administration has approved over-the-counter sales of the overdose reversal agent Narcan (naloxone, Emergent BioSolutions). Greater access to the drug should mean more lives saved. However, [...]

Published
2023

44. APTI to set up its headquarters at Soldevanahalli in Bengaluru; Phase-1 to cost Rs. 12-14 crore

Subjects
Societies -- Economic aspects, School construction -- Economic aspects, Pharmacy -- Economic aspects, Associations, institutions, etc. -- Economic aspects, Pharmaceuticals and cosmetics industries
Abstract

Byline: Nandita Vijay The Association of Pharmacy Teachers of India (APTI) has received land to set up its headquarters office within the campus of Acharaya BM Reddy College of Pharmacy [...]

Published
2022

45. Philip Morris making deals with Australian pharmacies to supply below-cost vaping products; VEEV nicotine pods and devices offered at an 80% margin on the condition pharmacies sign supply deal with the tobacco giantGet our morning and afternoon news emails, free app or daily news podcast

Subjects
Philip Morris International Inc., Podcasting -- Economic aspects, Pharmacists -- Economic aspects, Tobacco industry -- Economic aspects, Electronic mail systems -- Economic aspects, Drugstores -- Economic aspects, Pharmacy -- Economic aspects, E-mail, News, opinion and commentary
Abstract

Byline: Melissa Davey Medical editor Tobacco company Philip Morris International has made a deal with some Australian pharmacies to supply its VEEV vaping products below cost, despite the company's opposition [...]

Published
2023

46. Corey Dunham, Syracuse COO, Discusses State Of Emergency As Massive Storm Arrives In NY; Migrants Wait In Cold At Border For Chance To Request Asylum; WH Cautiously Optimistic About Economy In 2023 On Heels Of New Data; Winter Storm Impacting Shipping For Last- Minute Gifts; Iowa Sports Reporter Not Happy About Filling In On Weather Coverage; Empty Pharmacy Shelves Shine Light On U.S. Drug Supply Problems. Aired 2:30-3p ET

Subjects
Journalists -- Economic aspects, Chief operating officers -- Economic aspects, Pharmacy -- Economic aspects, News, opinion and commentary
Abstract

[14:30:00] KRISTIN FISHER, CNN HOST: So New York Governor Kathy Hochul has declared a state of emergency as this massive storm begins to move across the state. Blizzard and windchill [...]

Published
2022

48. Celltrion USA Announces Distribution and Incorporation of YUFLYMA(r) (adalimumab-aaty), a Humira(r) Biosimilar, to CarePartners Specialty Pharmacy Cost Savings Programs

Subjects
Adalimumab -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, Evidence-based medicine -- Economic aspects, General interest, News, opinion and commentary, Yuflyma (Medication), Humira (Medication)
Abstract

JERSEY CITY: Celltrion USA, Inc. (Celltrion USA) today announced its FDA-approved biosimilar, YUFLYMA(r) (adalimumab-aaty), has been added to CarePartners Specialty Pharmacy Cost Savings Programs. YUFLYMA is a high-concentration (100mg/mL) and [...]

Published
2023

49. Celltrion USA announces distribution and incorporation of YUFLYMA[R] (adalimumab-aaty), a Humira[R] biosimilar, to CarePartners Specialty Pharmacy Cost Savings Programs

Subjects
United States. Food and Drug Administration, Adalimumab -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, Evidence-based medicine -- Economic aspects, Business, Business, international, Yuflyma (Medication), Humira (Medication)
Abstract

* YUFLYMA([R]) (adalimumab-aaty) was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available in the U.S. on July 2, 2023 * The treatment [...]

Published
2023

50. Mallinckrodt Presents Latest Health Economics Data on Acthar Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Subjects
United States. Food and Drug Administration, Mallinckrodt PLC, Health care industry -- Economic aspects, Managed care plans (Medical care) -- Economic aspects, Drug approval -- Economic aspects, Pharmacy -- Economic aspects, ACTH -- Economic aspects, Pharmaceutical industry -- Economic aspects, Health care industry, Business, News, opinion and commentary
Abstract

-- Findings from two health economics analyses of Acthar Gel provide further insight into its cost-effectiveness as a treatment option for advanced symptomatic sarcoidosis,[sup.1] and its impact on clinical, economic, [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results